Stockscreener 앱 받기
8.46
5.16%
-0.46
시장 영업 전:
8.46
전일 마감가:
$8.92
열려 있는:
$8.91
하루 거래량:
316.18K
Relative Volume:
0.26
시가총액:
$565.74M
수익:
-
순이익/손실:
$-103.21M
주가수익비율:
-1.8391
EPS:
-4.6001
순현금흐름:
$-26.70M
1주 성능:
+4.83%
1개월 성능:
-2.53%
6개월 성능:
+160.31%
1년 성능:
+28.38%
1일 변동 폭
$8.20
$9.14
1주일 범위
$7.75
$9.14
52주 변동 폭
$2.65
$11.14
Engene Holdings Inc Stock (ENGN) Company Profile
명칭
Engene Holdings Inc
전화
(514) 332-4888
주소
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
ENGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
8.46 | 596.50M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | 개시 | Piper Sandler | Overweight |
| 2025-02-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-12-23 | 개시 | H.C. Wainwright | Buy |
| 2024-11-27 | 개시 | Raymond James | Outperform |
| 2024-11-18 | 개시 | JMP Securities | Mkt Outperform |
| 2024-08-28 | 개시 | Oppenheimer | Outperform |
| 2024-04-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-03-28 | 개시 | UBS | Buy |
| 2024-03-08 | 개시 | Morgan Stanley | Overweight |
| 2024-02-20 | 개시 | Leerink Partners | Outperform |
모두보기
Engene Holdings Inc 주식(ENGN)의 최신 뉴스
enGene (NASDAQ:ENGN) Stock Price Up 8.2%Time to Buy? - MarketBeat
enGene (ENGN) Projected to Post Earnings on Thursday - MarketBeat
Holdings of enGene Holdings Inc (ENGN) are aligned with the stars - setenews.com
Market Recap: Can enGene Holdings Inc Equity Warrant stock attract ESG capital inflowsQuarterly Earnings Summary & Smart Money Movement Alerts - moha.gov.vn
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program - TipRanks
EnGene Holdings Inc (ENGN) surging after positive phase 2 LEGEND trial - MSN
enGene Holdings Inc (ENGN) Surging After Positive Phase 2 LEGEND Trial - Finviz
How enGene Holdings Inc. stock performs in rate cut cyclesJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program - Investing.com Nigeria
Franklin Resources Inc. Sells 136,866 Shares of enGene Holdings Inc. $ENGN - MarketBeat
9 Best Up and Coming Canadian Stocks to Buy - Insider Monkey
FDA selects enGene’s bladder cancer therapy for development program By Investing.com - Investing.com Australia
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readines - pharmiweb.com
enGene stock rises after FDA selects bladder cancer therapy for CMC pilot program - Investing.com Nigeria
Engene's detalimogene selected for FDA manufacturing pilot program to support manufacturing readiness - marketscreener.com
FDA selects enGene’s bladder cancer therapy for development program - Investing.com
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness - Yahoo Finance
What valuation multiples suggest for enGene Holdings Inc. Equity Warrant stockEarnings Performance Report & Risk Managed Investment Entry Signals - Newser
Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsForecast Cut & AI Optimized Trading Strategy Guides - moha.gov.vn
enGene Holdings Inc Stock Analysis and ForecastHealthcare Stock Analysis & Learn the Secrets of Pro Traders - earlytimes.in
enGene (NASDAQ:ENGN) Trading Up 6.9%Should You Buy? - MarketBeat
enGene Holdings Prices $130 Million Public Offering to Advance Genetic Medicine Programs - MSN
enGene to Present at Piper Sandler Healthcare Conference - TipRanks
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference - Markets Financial Content
PERCEPTIVE ADVISORS LLC's Strategic Acquisition in enGene Holdings Inc. - GuruFocus
Investors in cash trouble should check out enGene Holdings Inc (ENGN) - setenews.com
What drives enGene Holdings Inc Equity Warrant stock priceDebt-to-Equity Ratio Analysis & High Return Trading Ideas - earlytimes.in
enGene Holdings Inc. (ENGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is enGene Holdings Inc. stock a dividend growth opportunityBuy Signal & Momentum Based Trading Ideas - newser.com
How enGene Holdings Inc. Equity Warrant stock reacts to inflationary pressuresTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
How enGene Holdings Inc. stock compares to growth peersGap Down & Stock Timing and Entry Methods - newser.com
enGene Holdings Inc. (S0N.F) stock price, news, quote and history - Yahoo Finance UK
Is a relief rally coming for enGene Holdings Inc. holders2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Is enGene Holdings Inc. Equity Warrant trending in predictive chart modelsPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Is enGene Holdings Inc. Equity Warrant stock bottoming out2025 Top Decliners & Daily Entry Point Alerts - newser.com
Multi asset correlation models including enGene Holdings Inc. Equity WarrantWeekly Trade Recap & Verified Momentum Watchlists - newser.com
How institutional buying supports enGene Holdings Inc. stockQuarterly Investment Review & Safe Entry Trade Reports - newser.com
Engene Holdings Inc (ENGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):